85330-50-3 Usage
Description
2H-Benzimidazol-2-one,1,3-dihydro-4-nitro-(9CI) is a chemical compound with the molecular formula C7H6N4O3. It is a derivative of benzimidazole, which is a heterocyclic compound containing a benzene ring fused to an imidazole ring. The 4-nitro group on this compound makes it a nitrobenzimidazole, which is a class of compounds often used in pharmaceuticals, agrochemicals, and dyes.
Uses
Used in Pharmaceutical Industry:
2H-Benzimidazol-2-one,1,3-dihydro-4-nitro-(9CI) is used as a drug candidate for various therapeutic purposes due to its potential medicinal properties.
Used in Organic Synthesis:
2H-Benzimidazol-2-one,1,3-dihydro-4-nitro-(9CI) is used as an intermediate in organic synthesis, taking advantage of its electron-withdrawing nitro group for further chemical reactions.
Used in Agrochemicals:
2H-Benzimidazol-2-one,1,3-dihydro-4-nitro-(9CI) is used as a component in agrochemicals, contributing to the development of pesticides and other agricultural products.
Used in Dyes:
2H-Benzimidazol-2-one,1,3-dihydro-4-nitro-(9CI) is used in the production of dyes, where its chemical structure provides color and stability to the final product.
It is important to handle this compound with care, as nitro compounds can be explosive under certain conditions. Overall, 2H-Benzimidazol-2-one,1,3-dihydro-4-nitro-(9CI) is an important chemical compound with potential applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 85330-50-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,3,3 and 0 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 85330-50:
(7*8)+(6*5)+(5*3)+(4*3)+(3*0)+(2*5)+(1*0)=123
123 % 10 = 3
So 85330-50-3 is a valid CAS Registry Number.
85330-50-3Relevant articles and documents
Preparation method of 4-amino-1, 3-dihydro-benzimidazole-2-one
-
, (2020/07/15)
The invention provides a preparation method of 4-amino-1, 3-dihydro-benzimidazole-2-one, which comprises the following steps: Q1, preparation of 2, 6-dinitrochlorobenzene, Q2, preparation of 2, 6-dinitroaniline, Q3, preparation of 3-nitro-o-phenylenediamine, Q4, preparation of 4-nitro-1H-benzo[d]imidazole-2(3H)-one and Q5, preparation of 4-amino-1, 3-dihydro-benzimidazole-2-one. According to the preparation method, 3, 5-dinitro-4-chlorobenzoic acid which is low in price is used as a raw material, and the high-yield 4-amino-1, 3-dihydro-benzimidazole-2-one is obtained through reactions such asdecarboxylation and ammoniation. The whole reaction process is easy to control, the product yield is high, good social benefits and economic benefits can be brought, and the economic value potential is large.
TRICYCLIC INHIBITORS OF PRO-MATRIX METALLOPROTEINASE ACTIVATION
-
Page/Page column 39, (2012/06/01)
This invention relates to tricycle I and its therapeutic and prophylactic uses, wherein the variables C1, C2, Z1, Z2, Q, J, R1, and R3 are defined in the specification. Disorders treated and/or prevented include rheumatoid arthritis.
TRPV1 vanilloid receptor antagonists with a bicyclic portion
-
Page/Page column 11, (2011/11/01)
The invention discloses compounds of formula I wherein Y s selected from a group of formula and W, Q, n, R1, R2, R3, U1-U5 have the meanings given in the description. The compounds of formula I are TRPV1 antagonists and are useful as active ingredients of pharmaceutical compositions for the treatment of pain and other conditions ameliorated by the inhibition of the vanilloid receptor TRPV1. 1.
